Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Merck
Chubb
Cipla
Novartis
UBS
Covington
Healthtrust
Harvard Business School

Generated: October 16, 2017

DrugPatentWatch Database Preview

Mesna - Generic Drug Details

« Back to Dashboard

What are the generic sources for mesna and what is the scope of mesna patent protection?

Mesna
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Sagent Pharms, West-ward Pharms Int, Baxter Hlthcare, Mylan Labs Ltd, Teva Pharms Usa, and Mylan Institutional, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for mesna. Five suppliers are listed for this compound.

Summary for Generic Name: mesna

US Patents:0
Tradenames:2
Applicants:7
NDAs:8
Drug Master File Entries: see list10
Suppliers / Packagers: see list5
Bulk Api Vendors: see list72
Clinical Trials: see list129
Patent Applications: see list34
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mesna at DailyMed

Pharmacology for Ingredient: mesna

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
MESNEX
mesna
TABLET;ORAL020855-001Mar 21, 2002RXYesYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
MESNA
mesna
INJECTABLE;INTRAVENOUS075811-001Apr 26, 2001APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
MESNA
mesna
INJECTABLE;INTRAVENOUS203364-001Jul 18, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
MESNA
mesna
INJECTABLE;INTRAVENOUS076488-001Mar 8, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
MESNA
mesna
INJECTABLE;INTRAVENOUS075739-001Jan 9, 2004APRXNoNo► Subscribe► Subscribe► Subscribe
Sagent Pharms
MESNA
mesna
INJECTABLE;INTRAVENOUS090913-001Apr 13, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare
MESNEX
mesna
INJECTABLE;INTRAVENOUS019884-001Dec 30, 1988APRXYesYes► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
MESNA
mesna
INJECTABLE;INTRAVENOUS075764-001Apr 27, 2001APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mesna

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare
MESNEX
mesna
TABLET;ORAL020855-001Mar 21, 2002► Subscribe► Subscribe
Baxter Hlthcare
MESNEX
mesna
INJECTABLE;INTRAVENOUS019884-001Dec 30, 1988► Subscribe► Subscribe
Baxter Hlthcare
MESNEX
mesna
INJECTABLE;INTRAVENOUS019884-001Dec 30, 1988► Subscribe► Subscribe
Baxter Hlthcare
MESNEX
mesna
TABLET;ORAL020855-001Mar 21, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Deloitte
US Army
Queensland Health
Johnson and Johnson
QuintilesIMS
Julphar
Merck
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot